Group Post |
WHO report: COVID-19 vaccines may be less effective against Omicron, delta still dominant but declining slightly - WHO |
mike kraft |
Group Post |
WHO renames monkeypox as mpox, citing racism concerns |
mike kraft |
Group Post |
WHO renames lineages of monkeypox, moving away from geographic links |
FNUOvviyaa |
Group Post |
WHO releases strategy paper on COVID disease management and long-term disease prevention |
mike kraft |
Group Post |
WHO releases global COVID-19 vaccination strategy update to reach unprotected |
FNUOvviyaa |
Group Post |
WHO release on beginning of COVAX vaccine shipments |
mike kraft |
Group Post |
WHO reform needed in wake of pandemic, public health experts say |
mike kraft |
Group Post |
WHO recommends reduced dose Pfizer COVID vaccine for under 12s |
mike kraft |
Group Post |
WHO recommends antibody treatment for some COVID-19 patients |
mike kraft |
Group Post |
WHO recomends 2 monoclonal antibodies for severe COVID |
mike kraft |
Group Post |
WHO posts 2nd daily record for new cases in row |
mike kraft |
Group Post |
WHO plans slew of COVID-19 vaccine approvals for global rollout - document |
mike kraft |
Group Post |
WHO panel to recommend 'deeper' study in China of early Covid-19 clues |
mike kraft |
Group Post |
WHO panel backs use of Omicron-adapted vaccine as booster dose |
FNUOvviyaa |
Group Post |
WHO official warns dengue fever, a painful disease. will become a major threat this decade |
mike kraft |
Group Post |
WHO official says Covid booster jabs ‘not a luxury’ and protect the vulnerable |
mike kraft |
Group Post |
WHO official opposes boosters before 1st vaccines reach poor countries |
mike kraft |
Group Post |
WHO new graphics on the world wide spread of COVID-19 |
mike kraft |
Group Post |
WHO needs reforms, while preserving 'political independence': panel |
mike kraft |
Group Post |
WHO Monkeypox Research - What study designs can be used to address the remaining knowledge gaps for monkeypox vaccines? |
FNUOvviyaa |
Group Post |
WHO member states agree to fix 'rotten' funding model |
mike kraft |
Group Post |
WHO Meeting warns Coronavirus pandemic will be with us for a long time |
mike kraft |
Group Post |
WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission... |
mike kraft |
Group Post |
WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use |
mike kraft |
Group Post |
WHO lays out plan to emerge from emergency phase of pandemic |
mike kraft |
Recent Comments